Identification and validation of a prognostic signature and combination drug therapy for immunotherapy of head and neck squamous cell carcinoma

Identification and validation of a prognostic signature and combination drug therapy for immunotherapy of head and neck squamous cell carcinoma

Immunotherapy has become a promising therapeutic option for Head and neck squamous cell carcinoma (HNSC). However, only a small percentage of patients could benefit from it, and the overall prognosis was far from satisfactory. In this study, by comprehensively computational analyses of hundreds of H...

Full description

Bibliographic Details
Main Authors: Weijie Qiang, Yifei Dai, Xiaoyan Xing, Xiaobo Sun
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Computational and Structural Biotechnology Journal
Subjects:
Head and neck squamous cell carcinoma
Cancer immunotherapy
Prognostic signature
Bioinformatics
Molecular docking
Online Access:http://www.sciencedirect.com/science/article/pii/S2001037021000507

Internet

http://www.sciencedirect.com/science/article/pii/S2001037021000507

Similar Items